Price target
29.600.000.00%
The 15 analysts offering 1 year price forecasts for MYGN have a max estimate of — and a min estimate of —.
Analyst rating
Based on 16 analysts giving stock ratings to MYGN in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
MYGN EPS for the last quarter is 0.05 USD despite the estimation of −0.01 USD. In the next quarter EPS is expected to reach 0.02 USD. Track more of Myriad Genetics, Inc. financials and stay on top of what is up with the company.
In the next quarter Myriad Genetics, Inc. revenue is expected to reach 210.76 M USD. Check out Myriad Genetics, Inc. revenue and earnings and make informed decisions.
According to analysts, MYGN price target is 29.60 USD with a max estimate of 40.00 USD and a min estimate of 16.00 USD. Check if this forecast comes true in a year, meanwhile watch Myriad Genetics, Inc. stock price chart and keep track of the current situation with MYGN news and stock market news.
We've gathered opinions of 16 analysts rating MYGN stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as neutral. Note that it's not a trading advice — your own analysis is still required.